London-based Semble, a healthcare software program firm, introduced on Tuesday that it has secured $15M (roughly €13.8M) in a Sequence B funding spherical led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures, and Triple Level.
The corporate will use the funds to consolidate its place within the UK market and increase its presence in France, the place it launched earlier this month.
This newest Sequence B spherical brings the entire raised to $27M (roughly €24.9M).
Christoph Lippuner, CEO, says, “Amplifying the influence of healthcare professionals is central to our mission. For too lengthy, they’ve labored with outdated programs that take them away from what issues most – the affected person. With this newest funding, we need to deliver Semble to professionals throughout the UK and France, empowering them to spend extra time on affected person care. We are going to proceed to take a position closely in workflow automation and integrations, positioning Semble on the forefront of AI-driven options, and in the end making a extra related healthcare ecosystem.”
Semble: Offering built-in scientific system
Christoph Lippuner and Mikael Landau based Semble in 2018 after experiencing challenges within the healthcare sector. They based the corporate to scale back the executive burden on medical professionals.
Semble is an built-in scientific system designed for healthcare companies of all sizes.
The system allows healthcare companies to automate duties whereas offering safe affected person knowledge change by integrating with third-party programs, corresponding to hospitals, laboratories, and pharmacies.
At the moment, the platform is utilized by over 10,000 healthcare professionals throughout the UK and France, supporting greater than 70 specialties.
To amplify the influence on healthcare professionals, the UK firm enhances operational efficiencies, hastens medical and admin duties, improves interoperability, and unlocks the facility of knowledge for the healthcare trade.
The buyers
Mercia Ventures is a proactive enterprise capital investor that makes fairness investments of as much as £10M throughout all sectors, with specialisms in Software program, Shopper, Healthcare, and Deep Tech.
The Group has 11 workplaces within the UK and Mercia Ventures’ nationwide footprint and 48-strong funding staff attracts on their experiences as founders, PhD scientists, software program engineers, company financiers, and administration consultants to assist its associate firms efficiently obtain their ambitions.
Alex Gwyther of Mercia Ventures provides, “The healthcare market is experiencing vital development, however the trade’s continued reliance on legacy programs poses an actual risk to its future. Semble is pioneering an all-in-one scientific system that allows healthcare companies to automate many features of their observe. This funding will assist Semble speed up product improvement and increase its presence within the UK and France, empowering healthcare organisations to ship on their digital transformation and rework their sufferers’ expertise. With the founders’ first-hand understanding of the challenges within the healthcare sector and its fast development so far, we’re in little question that Semble is nicely poised to grab this huge market alternative.”
